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ABSTRACT
Ethanol exposure during pregnancy is an established cause of birth
defects, including neurodevelopmental defects. Most adult neurons
are produced during the second trimester-equivalent period. The
fetal neural stem cells (NSCs) that generate these neurons are an
important but poorly understood target for teratogenesis. A cohort
of miRNAs, including miR-153, may serve as mediators of
teratogenesis. We previously showed that ethanol decreased,
while nicotine increased miR-153 expression in NSCs. To
understand the role of miR-153 in the etiology of teratology, we
first screened fetal cortical NSCs cultured ex vivo, by microarray
and quantitative RT-PCR analyses, to identify cell-signaling mRNAs
and gene networks as important miR-153 targets. Moreover, miR-
153 over-expression prevented neuronal differentiation without
altering neuroepithelial cell survival or proliferation. Analysis of
39UTRs and in utero over-expression of pre-miR-153 in fetal mouse
brain identified Nfia (nuclear factor-1A) and its paralog, Nfib, as
direct targets of miR-153. In utero ethanol exposure resulted in
a predicted expansion of Nfia and Nfib expression in the fetal
telencephalon. In turn, miR-153 over-expression prevented, and
partly reversed, the effects of ethanol exposure on miR-153 target
transcripts. Varenicline, a partial nicotinic acetylcholine receptor
agonist that, like nicotine, induces miR-153 expression, also
prevented and reversed the effects of ethanol exposure. These
data collectively provide evidence for a role for miR-153 in
preventing premature NSC differentiation. Moreover, they provide
the first evidence in a preclinical model that direct or
pharmacological manipulation of miRNAs have the potential to
prevent or even reverse effects of a teratogen like ethanol on fetal
development.
KEY WORDS: Fetal alcohol syndrome, Alcohol, Neural stem/
progenitor cells, miR-153, Nfia, Nfib, Nicotine, Varenicline
INTRODUCTION
Neural stem cells (NSCs), within the human fetal ventricular zone
(VZ), generate most neurons of the adult human brain during a
restricted developmental window encompassing the end of the
first trimester, through the second trimester of pregnancy
(Bystron et al., 2008). In rodent models, this neurogenic-
equivalent period encompasses the second half of pregnancy
(Noctor et al., 2004; Takahashi et al., 1995). The rate of drug
abuse among pregnant women is also highest during these
trimesters (SAMHSA, 2009). Therefore, the peak period for
maternal consumption of drugs like alcohol, a causative factor in
the etiology of the fetal alcohol syndrome (FAS (Jones et al.,
1973)), coincides with, and is therefore likely to interfere with the
critical period for fetal neurogenesis. In rodent models, maternal
ethanol exposure during this neurogenic period has been shown to
result in fetal brain growth deficits (Kotkoskie and Norton, 1989;
Miller and Nowakowski, 1991; Sudheendran et al., 2013).
Importantly, these deficits were not due to NSC death, but
rather due to NSC depletion by loss of renewal and premature
maturation (Prock and Miranda, 2007; Santillano et al., 2005;
Tingling et al., 2013).
A question that arises is ‘‘What molecular mechanisms mediate
fetal NSC vulnerability and contribute to teratology associated with
maternal drug abuse?’’. MicroRNAs (miRNAs), a class of small
noncoding RNAs that regulate the translation of networks of protein-
coding genes, have long been known to control development
(Pasquinelli et al., 2000). Therefore, we hypothesized that miRNAs
would mediate the effects of teratogens on the growth and
maturation of fetal NSCs.
MiR-153, a brain-enriched (Sempere et al., 2004),
evolutionarily conserved miRNA located within the PTPRN2
gene locus, is a candidate mediator of teratogenesis. We
identified miR-153 as one of a small cohort of miRNAs that
were significantly decreased in fetal NSCs, following ethanol
exposure (Sathyan et al., 2007). In that, and subsequent
studies (Pappalardo-Carter et al., 2013), we also showed that
the suppression of ethanol-sensitive miRNAs individually and
collectively, explained some of the teratogenic effects of ethanol.
Recently, developmental ethanol exposure was shown to also
result in decreased miR-153 in a zebrafish model, and
dysregulation of miR-153 in that model in turn resulted in
neurobehavioral impairment (Tal et al., 2012). Moreover,
nicotine also influenced miR-153 expression (Balaraman et al.,
2012), suggesting that miR-153 is a target for other teratogenic
agents and drugs of abuse.
In the following series of experiments, we identified cell-
signaling gene networks as important targets of miR-153 in fetal
cortical NSCs. We further identified the Nfia (nuclear factor-1A)
and its paralog, Nfib as direct targets of miR-153, and showed
that these and other miR-153 target transcripts were also up-
regulated following ethanol exposure. Importantly, we present
evidence showing that miR-153 prevents, and even partly
reverses the effects of ethanol exposure. Moreover, varenicline,
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a partial nicotinic acetyl choline receptor (nAChR) agonist
(Mihalak et al., 2006), prevented and reversed the effects of
ethanol on miR-153 target transcripts. Collectively, these
data provide evidence for the efficacy of miRNA-mediated
mechanisms in preventing and even reversing effects of teratogen
exposure in fetal NSCs.
RESULTS
To better understand how miRNAs like miR-153 may mediate
teratogenesis, we over-expressed miR-153 in fetal NSCs for
24 hours in a transient transfection assay (see Fig. 1a for map
of expression construct). Transfection (at an efficiency of
,6862%) yielded populations of cells expressing moderate
and high levels of GFP (Fig. 1b). Comparative analysis of miR-
153 (Exiqon miRCURY qPCR arrays, using previously published
protocols (Balaraman et al., 2014)) indicates that miR-153 in
untransfected control NSCs is expressed at the upper 12th
percentile of all expressed miRNAs. Transfection with the miR-
153 expression construct resulted in a ,32-fold induction of
miR-153 compared to the transfection control (t(10)528.33,
p,8.27e206, Fig. 1c,d), increasing the relative expression of
miR-153 to the upper 1st percentile of all expressed miRNAs
(Fig. 1d). At this level of expression, miR-153 is 2.5-fold
less abundant than miR-9, another ethanol-sensitive miRNA
(Balaraman et al., 2012; Pappalardo-Carter et al., 2013; Sathyan
et al., 2007). Therefore, transfection with the miR-153 expression
construct resulted in significant over-expression of miR-153,
although within the range of miRNA expression observed in
NSCs.
Following transfection with control-GFP or miR-153-GFP
expression vectors, neurosphere-derived cells were cultured for
an additional 48 hours on a laminin substrate, in a mitogen-
withdrawal-induced differentiation paradigm that has previously
been shown to result in transformation of NSCs into early
migratory neurons (Camarillo et al., 2007; Camarillo and
Miranda, 2008; Tingling et al., 2013). Control NSCs exhibited
morphological transformation into bipolar and multipolar cells
with elongated processes (Fig. 2a.i–a.iii), whereas miR-153-GFP
transfected cells exhibited deficient morphological transformation
(Fig. 2b.i–b.iv). However, both control-GFP and miR-153-GFP
over-expressing cells expressed immunofluorescence for MAP2a/b
(Fig. 2c.i–c.iii vs Fig. 2d.i–d.iii), an early-appearing neuronal
Fig. 1. Identification and gene ontology
classification of mRNAs that are down-
regulated following miR-153 over-expression.
(a) Schematic structure of the pre-miR-153/GFP-
puromycin expression vector (Cell Biolabs, CA).
(b) Sample flow-cytometry frequency histograms
documenting transfection efficiency. The upper
panel depicts mock-transfected controls, whereas
the lower two panels (s1 and s2) show GFP
expression following transfection. GFP-transfected
cells exhibit a bi-modal distribution, with a mean
transfection efficiency of 6862%. Cells were
cultured for 24 hours before labeling with anti-GFP
antibody, followed by flow cytometry. (c) Bar graph
shows that transfection of neurosphere-derived
cells with pre-miR-153 expression vector results in
a 30-fold increase in miR-153 expression
compared to transfection with vector control. Data
from six independent replicates (n56) are
expressed as mean6SEM. (d) Frequency
histogram of miRNA expression (DCT relative to U6
snRNA) in neurosphere cultures showing the
relative baseline and transfection-induced
expression of miR-153. Smaller DCT values
indicate increased expression. Data show that
baseline miR-153 expression is within the upper
12th percentile of all expressed miRNAs, and that
over-expression results in a shift to the 1st
percentile. However, another ethanol-sensitive
miRNA, miR-9 (indicated with arrow), is expressed
at a higher baseline level compared to miR-153
over-expression.
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marker (Papandrikopoulou et al., 1989), indicating that miR-153
over-expressing cells retain at least some aspects of neuronal
lineage commitment, despite reduced neurite extension. It is
possible that longer periods of miR-153 over-expression may result
in a more profound suppression of differentiation. In strongly GFP-
labeled cells, GFP fluorescence completely overlapped with
MAP2a/b immuno-label, and therefore neurite outgrowth was
assessed in cells that expressed strong GFP label (Fig. 2d). Sholl
analysis (Fig. 2e) indicated that differentiating cells over-
expressing GFP-miR-153 had significantly shorter neurites
compared to cells transfected with the control GFP plasmid
(Multivariate Analysis of Variance–Pillai’s Trace Statistic
(MANOVAPTS), F(10,49)55.11, p,4.35E205). However, miR-
153 over-expression did not result in significant apoptosis (Fig. 2f)
or change in cell proliferation (Fig. 2g).
Identification of miR-153-regulated candidate genes
To assess the mechanisms underlying miR-153 mediated
suppression of differentiation we performed microarray analysis
to first identify miR-153 targets in fetal NSCs. Transcript profiles
were assessed from RNA samples obtained 24 hours following
transfection with GFP/miR-153 or GFP control vectors (6
independent replicates in each condition, microarray data
submitted to NCBI-GEO (accession number GSE49684)). Data
analysis showed that miR-153 over-expression resulted in
statistically significant down-regulation of 133 genes (at a false
discovery rate a50.1, of a total of 860 transcripts down-regulated
by §1.3-fold, Fig. 3a; Table 1). Ontology analysis showed that
there was a negative correlation between ontologies associated with
down-regulated and up-regulated transcripts (Pearson’s r520.592,
p,0.1E210, Fig. 3b), indicating that the functions of the down-
regulated, including presumably conventionally 39UTR-targeted
mRNAs, did not overlap with the functions of the up-regulated
genes. Transcripts that were down-regulated following miR-153
over-expression were significantly overrepresented in ontological
categories related to synaptic transmission and G-protein coupled
receptor (GPCR) signaling (Table 2). Moreover, pathway analysis
(Kyoto Encyclopedia of Genes and Genomes, KEGG) identified
‘‘Neuroactive ligand–receptor interaction’’ as a significantly
suppressed pathway. These bioinformatics analyses suggest that
in NSCs, miR-153 suppresses pathways that are important for the
function of differentiated neurons.
Fig. 2. Effects of miR-153 over-expression on differentiation, apoptosis and cell proliferation. (a,b) Photomicrographs depicting GFP immunofluorescent
cells cultured under mitogen-withdrawal-induced differentiation conditions on a laminin substrate 48 hours after transfection with GFP control vector (a.i–a.iii) or
with GFP-premiR-153 (b.i–b.iv). MiR-153 over-expressing cells exhibited deficient morphological transformation compared to control cells. (c,d) Differentiating
control-GFP (c.i–c.iii) and miR-153/GFP (d.i–d.iii) over-expressing cells exhibit co-localized expression of the early neuronal marker Map2a/b (white arrows).
Yellow arrowheads show that the GFP label fills the cellular processes and completely overlaps the expression of Map2a/b. Map2a/b immunolabeling also
shows deficient morphological transformation following miR-153/GFP over-expression. (e) Bar graph depicts Sholl analysis of neurite length expressed as
number of intersections (y-axis) as a function of distance from soma (x-axis) per cell. MiR-153 over-expressing cells have shorter neurites compared to controls.
Data based on analysis of 34 control and 26 miR-153-over-expressing cells. Photomicrographs were obtained from all four quadrants of each culture dish, and
cells whose processes showed no overlap with those of an adjacent cell were selected for analysis. Asterisks, all p-values ,0.02. (f) Pan-caspase activity was
measured as an estimate of apoptosis. Caspase activity was high in U937 cells treated with camptothecin (4 mg/ml for four hours, positive control) and
staurosporine (2 mM for two hours)-treated neurosphere cultured cells and low in neurosphere cultures transfected with control or pre-miR-153 expressing
vectors. There was no statistically significant difference between the latter two conditions (n56). (g) EdU incorporation into DNA was used as a marker for
cell proliferation. The percentage of labeled cells was not significantly different indicating that cell proliferation was not altered by miR-153 overexposure. Data
based on three independent transfection experiments. One photomicrograph was obtained from each quadrant of the culture well (three culture wells per
sample) and labeled and total number of cells counted. Scale bars: 100 mm.
RESEARCH ARTICLE Biology Open (2014) 000, 1–18 doi:10.1242/bio.20147765
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Interestingly, miRNAs are also known to induce gene expression
by binding to alternate target sites outside 39UTRs, including
promoter regions (Place et al., 2008). In silico analysis (MirWalk,
(Dweep et al., 2011)) of the top six statistically significantly
induced RNA transcripts, Patl2, Dhrs13, Rps25, Rai14, Foxo3, and
EG665934/GM7854 (FDR-corrected a50.02), predicted that two,
Rai14 and Rps25, each contained a miR-153 target site with a seed
region of 9 nt in length (p,0.037) within the presumptive
promoter, a 2 kb upstream gene flanking region. The sixth target,
EG665934/GM7854, a candidate long noncoding RNA (lncRNA),
is predicted (RNAhybrid, (Kru¨ger and Rehmsmeier, 2006)) to
contain a miR-153 target site with a 10 nt seed region. The
possibility that these are functional sites remains to be determined.
However, these data do suggest the possibility that some of the
induced transcripts may be direct targets of miR-153 as well.
Nineteen genes were selected for further assessment. These
included 10 candidate miR-153-repressed transcripts that reached
an FDR-corrected p,0.1 (Aplp2, Arl2bp, Ccl2, Cxcl1, Ddit4,
Fbxo2, Hdac8, Matn2, Nfic, Rab13), and 4 with an uncorrected
p,0.05 (Ccl7, Mid1, Mtap1s, Vegfa). Three genes, Akt1, Foxj2,
and Mkln, were chosen as validation controls that were not
statistically significantly altered by miR-153 over-expression.
Additionally, because the microarray screen identified Nfic as a
candidate target for miR-153, we also assessed other members of
the nuclear factor family, Nfia and Nfib. The Nfia family is a
particularly important target because of their implicated role in
suppressing NSC self-renewal (Namihira et al., 2009; Piper et al.,
2010), promoting gliogenesis (Barry et al., 2008; Deneen et al.,
2006), and neuronal differentiation and migration (Wang
et al., 2010). Moreover, Nfia haplo-insufficiency is associated
with brain malformations including agenesis of the corpus
callosum, ventriculomegaly, and Chiari-type-1 malformations
(Lu et al., 2007), features associated with fetal alcohol exposure.
None of the validation control mRNAs were altered following
miR-153 over-expression. Among the genes that met the
adjusted-p,0.1 criteria, Arl2bp (t(10)53.09, p,0.01), Ccl2
(t(10)53.14, p,0.01), Ddit4 (t(10)52.70, p,0.02), Fbxo2
(t(10)52.48, p,0.03), Hdac8 (t(10)53.66, p,0.004) and
importantly, Nfia, Nfib and Nfic (t(10)52.67, p,0.024;
t(10)55.49, p,0.001; t(10)55.28, p,0.001, respectively,
Fig. 4a), were significantly decreased following miR-153 over-
expression in the validation experiment. Among the cohort of
Fig. 3. Microarray analysis of gene expression following miR-153 over-expression. (a) Volcano-plot illustrates relationship between log2(mRNA
expression ratio) and log2(FDR-corrected p-value) in miR-153 over-expressing cultures compared to controls. Filled red and blue circles indicate mRNA transcripts
that are suppressed or induced, respectively, by more than 1.3-fold following miR-153 over-expression, at an FDR (Benjamini and Hochberg)-adjusted p,0.1.
Gray circles indicate genes that reached statistical significance at a raw p,0.05. Data summarized from 6 independent replicate experiments. (b) The plot
shows the correlation of gene ontology analysis of mRNA transcripts that were suppressed and induced following miR-153 over-expression. The x-axis depicts the
z-score of ontology analysis of mRNAs induced bymiR-153. The y-axis indicates the z-score of ontology analysis of mRNAs suppressed bymiR-153. The red line is
the regression line that indicates a negative linear relationship between ontology classes of miR-153 suppressed and induced mRNA transcripts.
Table 1. Sample miR-153 candidate gene targets from microarray analysis
Gene ID Gene identifier Ratio p-value Adj. p-value
Aplp2 NM_009691 1.47 0.0007 0.07
Fbxo2 NM_176848 1.34 0.0006 0.07
Rab13 NM_026677 1.5 0.003 0.07
Nfic NM_026756 1.36 0.002 0.07
Cxcl1 NM_008176 2.71 0.007 0.08
Hdac8 AK011332 1.74 0.007 0.08
Arl2bp NM_024191 1.43 0.006 0.08
Matn2 NM_016762 1.32 0.01 0.09
Ddit4 NM_029083 1.89 0.01 0.10
Ccl2 NM_011333 1.87 0.02 0.10
Vegfa NM_009505 1.67 0.03 0.12
Mid1 CF536475 1.57 0.03 0.12
Mtap1s NM_173013 1.63 0.05 0.14
Ccl7 NM_013654 1.61 0.05 0.14
The table represents 10 candidate genes down-regulated in miR-153 over-expression with adjusted (Benjamini and Hochberg correction for multiple
comparisons) p-value ,0.1 and four additional genes chosen for validation with a raw p-value ,0.05. ‘‘Gene Identifier’’ indicates gene accession number from
GenBank and ‘‘Gene ID’’ represents Hugo Gene Nomenclature.
RESEARCH ARTICLE Biology Open (2014) 000, 1–18 doi:10.1242/bio.20147765
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genes that exceeded the ‘raw’ p,0.05 criterion, only Vegfa
(t(10)53.07, p,0.012, Fig. 4b) was significantly reduced
following miR-153 exposure in the validation sample.
Identification of 39UTR regulatory motifs in miR-153 targeted
transcripts
mRNAs that were down-regulated following miR-153 over-
expression may include both direct and indirect targets.
Moreover, miR-153 over-expression may block NSC
maturation, thereby indirectly uncovering gene expression
differences in the microarray analyses. To directly address
these possibilities, we first utilized bioinformatic tools
(Targetscan, http://www.targetscan.org) to perform an in silico
analysis 39UTRs. Nfia and Nfib each contained several predicted
miR-153 binding sites in their 39UTRs with high aggregate PCTs
(probability of conserved targeting (Friedman et al., 2009)) of
0.99 and 0.96, respectively, indicating that miR-153 interactions
with Nfia/Nfib 39UTRs are likely to be evolutionarily conserved.
Matn2 and Vegfa 39UTRs were assessed as controls. Matn2 was
not validated as a miR-153 target in our earlier miR-153 over-
expression study, scored a lower PCT of 0.78, and is predicted to
contain a 39UTR miR-153 target site in primates, but not rodents.
Vegfa 39UTR contained no predicted miR-153 binding sites,
although VEGFa mRNA was significantly reduced following
miR-153 transfection. Moreover, Vegfa is the most highly
expressed cytokine in proliferating NSCs, and its expression
levels decrease significantly with neural differentiation
(Camarillo et al., 2007), suggesting that this cytokine is
important for NSCs.
Luciferase-reporter constructs (Fig. 5a) containing murine
39UTRs of Nfia, Nfib, the negative controls, Matn2 and Vegfa,
and as a positive control, Luc153, were each transfected into
single cell suspensions derived from neurosphere cultures.
Some cell aliquots were also co-transfected with pre-miR-153
or control expression vectors. Additionally, antisense morpholino
oligonucleotides can be used to protect 39UTR target sites from
miRNAs, by interfering with miRNA-regulated translation (Choi
et al., 2007). We therefore co-transfected either scrambled
(control), or antisense morpholino oligonucleotides (Table 3;
Fig. 5b, Fig. 6a) into some samples, to mask predicted miR-153
binding sites. At the end of 24 hours, luciferase activity,
normalized to Renilla luciferase, was determined. Because of
their length, the 39UTR region within the Nfia and Nfib
transcripts were each fragmented into three parts and cloned
into separate constructs downstream from the luciferase reporter
(Fig. 5b, Fig. 6a).
MiR-153 over-expression resulted in a 60% reduction in
luciferase activity from the co-transfected luciferase expression
construct with miR-153 binding sites in the 39UTR (Luc153,
Fig. 5c, p,6.64E207). In the case of Nfia, miR-153 targeting
of Luc-Nfia-39UTR_a did not significantly repress luciferase
activity (Fig. 5d). However, miR-153 did repress luciferase
Table 2. List of major gene ontologies (GO) and KEGG pathways down-regulated by miR-153 with a Z-score .2.0 (indicating that
this ontology is over-represented among the regulated genes compared to 95% of all other possible ontologies and pathways)
GO ID
Number of
regulated genes
Number of
genes in set % Z-score
Gene ontology
Regulation of inhibitory postsynaptic membrane potential GO:0060080 3 10 30.00 10.08
Membrane hyperpolarization GO:0060081 3 16 18.75 7.83
Negative regulation of synaptic transmission GO:0050805 3 32 9.38 5.28
G-protein signaling, coupled to cAMP nucleotide second messenger GO:0007188 4 93 4.30 3.65
Regulation of synaptic transmission GO:0050804 5 172 2.91 2.97
Regulation of synaptic plasticity GO:0048167 3 78 3.85 2.9
Second-messenger-mediated signaling GO:0019932 5 201 2.49 2.56
Transmission of nerve impulse GO:0019226 8 436 1.83 2.29
Ion transport GO:0006811 13 845 1.54 2.26
G-protein coupled receptor protein signaling pathway GO:0007186 16 1160 1.38 2.06
KEGG pathway
Neuroactive ligand–receptor interaction map04080 9 287 3.135889 4.43
Metabolism of xenobiotics by cytochrome P450 map00980 3 62 4.83871 3.5
Fig. 4. RT-PCR validation of
candidate miR-153-regulated
mRNAs. Bar graphs depict the real
time RT-PCR quantification of mRNAs
in vector control and miR-153 over-
expression conditions for candidate
mRNA transcripts identified from the
microarray experiment that achieved
the adjusted p-value cut-off of 0.1
(a) and raw p-value of 0.05
(b), respectively. The y-axis indicates
normalized mRNA expression
(expressed as 1/2DCt relative to 18s
RNA). Data were expressed as
mean6SEM and quantified from 6
independent replicates (*p,0.001;
**p,0.05).
RESEARCH ARTICLE Biology Open (2014) 000, 1–18 doi:10.1242/bio.20147765
5
B
io
lo
g
y
O
p
e
n
 by guest on September 11, 2018http://bio.biologists.org/Downloaded from 
activity from the Luc-Nfia-39UTR_b and from the Luc-
Nfia-39UTR_c constructs (overall ANOVAs, F(6,28)517.23,
p,3.07E208, and F(4,18)54.59, p,0.01, respectively, Fig. 5e,f).
Masking morpholinos, Nfia_mask_ii and Nfia_mask_iii, but not
Nfia_mask_i, were able to completely protect against miR-153-
mediated translation repression. Collectively, these data indicate
that two out of four predicted miR-153 binding sites localized near
the end of the Nfia-39UTR (Nfia/NM_010905.37285–7306 and Nfia/
NM_010905.39451–9469) mediated miR-153 translation repression
in fetal neuroepithelial cells. Similarly, Nfib was a direct target of
miR-153. Translation of Luc-Nfib-39UTR_a (Fig. 6b) or Luc-
Nfib-39UTR_b (Fig. 6c) was not repressed by miR-153 over-
expression. However, translation of Luc-Nfib-39UTR_c (Fig. 6d)
was repressed by miR-153 over-expression (overall ANOVA,
F(4,18)54.6, p,0.01). The Nfib-mask_i morpholino protected the
second, more distally located predicted miR-153 binding site
(Nfib/NM_008687.56559–6566), located near the 39-end of the
39UTR, and prevented translation repression.
In silico analysis (Mfold, http://mfold.rna.albany.edu (Zuker,
2003)) of the folding of the Nfia 39UTR indicates that miR-153
target site Nfia/NM_010905.377285–7306 localizes to a complex
of branched stem–loop structures, whereas Nfia/NM_
010905.39451–9469 localized to a predicted linearized portion of
the 39UTR. However, both sites are positioned proximate to the
39 and 59 termini of the 39UTR (Fig. 7a). Analysis of Nfib-39UTR
folding showed that the Nfib/NM_08689.56559–6566 site, like Nfia/
NM_010905.39451–9469, was located within a region predicted to
assume a more linearized structure, in close physical proximity to
the 59 and 39-ends of the 39UTR (Fig. 7b). These data indicate
that miR-153 binding sites within Nfia and Nfib 39UTRs are
positioned to influence translation activity within the open
reading frame (ORF). Neither Matn2 nor Vegfa 39UTRs
Table 3. Sequences of morpholino oligonucleotides
Control 59-GTGTAACACGTCTATACGCCCA-39
NFIA-mask_i 59-GTTTGCATATTCTTGTGGGCTGACT-39
NFIA-mask_ii 59-TAGTGCATAGTTCTCATGCAGGTAA-39
NFIA-mask_iii 59-TTGCATAGGAAATGCAGTACTTGCT-39
NFIB-mask_i 59-TTGCATAGGAAATATATCCGCTTCC-39
Fig. 5. Identification of Nfia 39UTR as a direct target of miR-153. (a) Schematic structure of the luciferase reporter constructs containing murine Nfia 39UTR
fragments (GeneCopoeia, Rockville, MD). (b) Schematic of the full length of Nfia 39UTR depicting the location of the three Nfia 39UTR fragments (Nfia 39UTR_a
in blue, Nfia 39UTR_b in orange, Nfia 39UTR_c in pink) that were cloned into luciferase reporters for studies. Green triangles indicate the predicted miR-153
binding sites that are conserved among vertebrates, whereas the blue triangle illustrates the predicted miR-153 binding site that shares conservation between
mouse and human. Purple bars represent the morpholinos used to protect the predicted miR-153 binding sites. (c) We assayed firefly activity relative to
RLuc luciferase activity in NSCs 24 h after transfection with the Luc_miR153 binding site reporter construct as the positive control and transfected control or
miR-153 mimetics. Bar graphs represent luciferase activity normalized to the mean activity of samples transfected with the miR-153 control vector. The x-axis
depicts treatment conditions. The y-axis indicates normalized luciferase activity. (d–f) NSCs were transfected with luciferase reporter constructs containing
different fragments of Nfia 39UTR, (d) 39UTR_a, (e) 39UTR_b, (f) 39UTR_c, with control or miR-153 mimetics for 24 hours. Additional control or antisense
morpholinos, (e) mask_i, mask_ii, and (f) mask_iii, used to protect the miR-153 binding sites were co-transfected along with other constructs as indicated on the
x-axis. Bars are normalized to the relative firefly units of samples treated with the transfected control. Data were expressed as mean6SEM (n55).
RESEARCH ARTICLE Biology Open (2014) 000, 1–18 doi:10.1242/bio.20147765
6
B
io
lo
g
y
O
p
e
n
 by guest on September 11, 2018http://bio.biologists.org/Downloaded from 
exhibited evidence for regulation by miR-153 (Fig. 8), indicating
that these were not direct miR-153 targets in NSCs.
MiR-153 modulates Nfia and Nfib expression in mouse fetal
brains
Evidence for translational regulation by miR-153 acting at
39UTRs suggested that Nfia and Nfib were direct miR-153
targets. We therefore further tested this association in an in vivo
model. Pre-miR-153-GFP or control-GFP expression constructs
were delivered to the telencephalic wall of GD13.5 fetuses by
intrauterine injection under ultrasound guidance (Fig. 9a)
followed by electroporation. After 48 hours (GD15.5), fetuses
were euthanized, fixed, and cryo-sectioned. The presence of anti-
GFP immunofluorescence was used as a localization marker
for cellular over-expression of miR-153. Following in utero
electroporation with the control-GFP vector, GFP-immuno-
reactivity was localized to the cytoplasm of cortical cells that also
expressed nuclear Nfia and Nfib (e.g. Fig. 9b–d) immuno-reactivity,
indicating that the expression vector did not non-specifically
interfere with target gene expression. In contrast, following in
utero electroporation of the pre-miR-153/GFP construct, GFP
immunopositive cells showed little-to-no immunofluorescence for
either Nfia or Nfib, whereas adjacent GFP-negative cells exhibited
strong nuclear localization of Nfia and Nfib immunoreactivity
(Fig. 9c1–c4,d1–d4,f1–f4,g1–g4). In adjacent regions of brain tissue
that exhibited little-to-no GFP immunofluorescence, the expression
and laminar organization of Nfia and Nfib were undisturbed
(Fig. 9e1–e3,h1–h3). However, in regions where there was strong
GFP immunofluorescence localized within the ventricular and sub-
ventricular zones, expression of Nfia and Nfib in the overlying
cortical plate was also disrupted (e.g. Fig. 9f4), although GFP itself
was not localized to the cortical plate. Finally, expression of
miR-153/GFP in groups of ventricular zone cells appeared to result
in compensatory Nfia and Nfib up-regulation in adjacent GFP-
negative cells (e.g. Fig. 9d4,g4, green vs purple arrows),
suggesting the presence of adaptive communication mechanisms
between adjacent neural progenitors. These data show that in vivo
over-expression of miR-153 results in disrupted translation from
target Nfia and Nfib mRNA transcripts.
HDAC8 lacks a predicted miR-153 target site within its 39UTR, but
we examined its expression following miR-153 over-expression
because it is the earliest type-1 HDAC to be expressed during
neurogenesis in the fetal murine telencephalon (Murko et al., 2010) and
is implicated in theetiologyof theWilson–TurnerX-linked(Harakalova
et al., 2012) and Cornelia de Lange (Deardorff et al., 2012) syndromes,
both of which are characterized by cognitive impairment. HDAC8-
immunoreactivitywas localizedpredominantly to thecytoplasmofcells
within the VZ and SVZ, consistent with previously observed
cytoplasmic localization in neural (Takase et al., 2013) and non-
neural (Waltregny et al., 2004) tissues. Although its mRNA transcript
was suppressed in neurosphere cultures following miR-153 over-
expression (Fig. 3), in vivo expression of HDAC8-immunoreactivity
was not altered by miR-153 over-expression (data not shown). This
discrepancy between mRNA and protein expression is consistent with
recent literature that suggests that class I HDAC family members are
stabilized by post-translational modification (Citro et al., 2013).
To further assess the role of miR-153 in neural differentiation,
we examined the expression of a marker for early migrating and
differentiating neurons (des Portes et al., 1998), doublecortin
(DCX), which is not predicted to contain a miR-153 binding site in
its 39UTR, and is therefore unlikely to be a direct miR-153 target.
Over-expression of miR-153/GFP within the SVZ coincided with
loss of expression of DCX-like immunofluorescence (Fig. 10b.i–b.iv
vs Fig. 10a.i–a.iv), indicating that miR-153 over-expression results
Fig. 6. Nfib is a direct target of miR-153. (a) Schematic shows the full length Nfib 39UTR in relation to the three 39UTR fragments (Nfib 39UTR_a in blue,
39UTR_b in green, 39UTR_c in purple) that were cloned into luciferase constructs for studies. Green triangles indicate the predicted miR-153 binding sites that
are conserved among vertebrates. Purple bars represent the morpholinos used to mask the miR-153 binding sites. (b–d) Firefly activity relative to RLuc
luciferase activity is determined in NSCs 24 h after transfection with luciferase reporter constructs containing different fragments of Nfib 39UTR, (b) 39UTR_a,
(c) 39UTR_b, (d) 39UTR_c, with control or miR-153 mimetics. Additional control or antisense morpholinos, (d) Nfib-mask_i, used to protect the predicted miR-153
binding sites in Nfib 39UTR were co-transfected into same samples as indicated. Data were normalized to the samples treated with the transfected control. The
x-axis depicts treatment conditions. The y-axis indicates normalized luciferase activity. Data were expressed as mean6SEM (n55).
RESEARCH ARTICLE Biology Open (2014) 000, 1–18 doi:10.1242/bio.20147765
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in a loss of neuronal differentiation, consistent with gene ontology
analyses reported above, which indicated that miR-153 over-
expression resulted in repression of differentiation-related mRNAs.
We previously showed that ethanol exposure resulted in decreased
expression of CD24, the neuronal lineage commitment marker, both
in vivo, and in neurosphere cultures (Tingling et al., 2013). However,
miR-153 over-expression did not result in altered expression of
CD24-immunofluorescence (Fig. 10d.i–d.iv vs Fig. 10c.i–c.iv),
indicating no effect on this ethanol-sensitive marker for neuronal-
lineage committed neural precursors. Moreover, miR-153 over-
expression also did not result in loss of MAP2a/b
immunofluorescence in newly differentiating neurons of the VZ
(Fig. 10e.i–e.iv), consistent with the lack of ex vivo effects of miR-
153 on MAP2a/b expression in neurosphere cultures (Fig. 2c,d).
Ethanol disrupts the expression pattern of Nfia and Nfib in
mouse fetal brains
We previously showed that ethanol exposure resulted in
decreased miR-153 expression in NSCs (Balaraman et al.,
2012; Sathyan et al., 2007). Since Nfia and Nfib were direct
targets of miR-153, we hypothesized that exposure to ethanol in
an in vivo model would result in an increased expression of these
factors. In utero ethanol exposure between GD12.5 and 14.5, i.e.
during the first half of the second trimester equivalent period of
cortical neurogenesis (Takahashi et al., 1995) results in an overall
thinning of the cortical plate (Fig. 11a.i vs Fig. 11b.i) accompanied
by ventriculomegaly as previously described (Sudheendran et al.,
2013). While control fetuses expressed Nfia (Fig. 11a.i–a.iii)
and Nfib (Fig. 11d.i–d.iii) mainly within the cortical plate,
ethanol-exposed fetuses exhibited a broader expansion of Nfia
(Fig. 11b.i,b.ii) and Nfib (Fig. 11e.i,e.ii) immunoreactivity
throughout the extent of the dorsal telencephalic wall, including
within the ventricular zone. At higher magnification (Fig. 11b.iii,
Fig. 11e.iii) Nfia and Nfib immunoreactivity could be observed in
mitotically active apical cells of the VZ in ethanol-exposed fetal
brains.
MiR-153 prevents and partly reverses effects of ethanol
exposure on mRNA transcript levels
We next tested the prediction that because of its suppressive
effect on miR-153, ethanol exposure would generally result in
increased expression of miR-153-sensitive mRNA transcripts. We
were also interested in examining the extent to which miR-153
could prevent or even reverse the effects of ethanol on NSCs.
Neurosphere cultures were exposed to control medium or to
ethanol, at a concentration (320 mg/dl) that was previously
shown to suppress miR-153 (Balaraman et al., 2012; Sathyan et
al., 2007), and was within the range of blood alcohol content
achievable in alcoholics (Adachi et al., 1991). To assess the
capacity of miR-153 to prevent ethanol’s effects (prevention
paradigm), some ethanol-treated cultures were concurrently
exposed to miR-153 by transient transfection. To assess the
capacity of miR-153 to reverse the effects of prior ethanol
exposure (reversal paradigm), other ethanol-treated cultures were
exposed to miR-153 for 48 hours following a five-day period of
ethanol exposure. Our data (Fig. 12) showed a global
(MANOVAPTS, F(36,56)52.786, p,0.001), as well as a transcript-
specific effect of treatment on mRNA expression (Nfia (ANOVA,
F(4,19)541.555, p,0.001), Nfib (F(4,19)516.609, p,0.001), Nfic
Fig. 7. In silico analysis of the RNA folding structure of Nfia and Nfib.
Predicted secondary structure conformation of the 39UTR of (a) Nfia and
(b) Nfib. Locations of the 59 and 39ends of the 39UTR sequences are marked
with blue arrows. (a) Two miR-153 binding sites, target_7285 and
target_9451, validated from luciferase assay above are shown on Nfia
39UTR. Target_7285 is located close to complex stem–loop structures, while
target_9451 localizes to a linear portion, of the Nfia 39UTR. MiR-153
sequences are shown in black while the matching binding site sequences are
illustrated in blue (target_7285) and red (target_9451). (b) One miR-153
binding site, target_6559, validated from luciferase analysis is located on the
linear portion of Nfib 39UTR and is labeled in red, whereas miR-153
sequence is shown in black.
Fig. 8. Matn2 and Vegfa are not direct targets of miR-153. Firefly activity
relative to RLuc luciferase activity was measured in NSCs 24 hours after
transfection with control or miR-153 mimetics and the luciferase construct
containing 39UTR of Matn2 or Vegfa. Bars are normalized to the relative
firefly units of samples treated with the transfected control. The x-axis depicts
treatment conditions (control or miR-153). The y-axis indicates normalized
luciferase activity. Data were expressed as mean 6 SEM (n55).
RESEARCH ARTICLE Biology Open (2014) 000, 1–18 doi:10.1242/bio.20147765
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(F(4,19)513.722, p,0.001), Ddit4 (F(4,19)55.313, p,0.004),
Hdac8 (F(4,19)517.715, p,0.001), and Arl2bp (F(4,19)514.9,
p,0.001)). Post-hoc analyses showed that ethanol exposure did
result in increased expression of Nfia (p,0.00003), Nfib
(p,0.045), Nfic (p,0.0007), Arl2bp (p,0.0002), Ddit4
(p,0.044), and Hdac8 (p,0.0004), and that simultaneous
over-expression of miR-153 prevented the inductive effect of
ethanol on these mRNA transcripts (cultures administered miR-
153 along with ethanol were not significantly different from
controls). The increased expression of Nfia and Nfib mRNA
following ethanol exposure validated the results from the in
vivo exposure paradigm (Fig. 11) and indicate that ethanol
directly influences Nfia/b expression in fetal neuroepithelial
cells, rather than indirectly, via altered maternal–fetal
physiology.
Over-expression of miR-153 after an episode of ethanol
exposure (the reversal paradigm), on the other hand, resulted in
varied outcomes. In the case of Ddit4 and Arl2bp, over-expression
Fig. 9. MiR-153 regulates Nfia and Nfib expression in fetal brains. (a) Photo-micrograph depicts ultrasound-guided trans-uterine insertion of a micro-capillary
pipette (dashed green line) into the lateral ventricle in a GD13 fetal brain. Following in utero electroporation of control-GFP or miR-153/GFP vectors, fetuses
were maintained for an additional period of 48 hours, before being analyzed at GD15.5. Double immunohistochemistry of anti-GFP with anti-Nfia or anti-Nfib in
control-GFP (b) or Pre-miR-153-GFP (c–h) transfected GD15.5 mouse frozen sections. (b1,b2) Photomicrograph shows (b1) control-GFP (green) localizes to
the cytoplasm of nuclear Nfib-labeled (red) neurons of the cortical plate and (b2) DAPI-counterstained nuclei. (c–h) Panels c1–h1, c2–h2 and c3–h3 show low
magnification images of the same sections counterstained with DAPI (c1–h1) to visualize nuclei, or immuno-fluorescently labeled for GFP (c2–h2) as a marker
for miR-153 over-expression, or Nfia (c3–e3) and Nfib (f3–h3). (c4,d4,f4,g4) High magnification photomicrographs showing that GFP expression from the pre-
miR-153/GFP construct does not co-localize with nuclear immuno-labeling for Nfia (c4,d4) or Nfib (f4,g4). Residual cytoplasmic labeling in GFP/miR-153 over-
expressing cells, represented by yellow immunofluorescence (e.g. c4), may represent incompletely suppressed translation or residual immuno-reactivity due to
products of stalled translation. Dotted circles indicate regions depicted in high magnification images. Dotted squares depict regions of cortical plate with
disrupted expression of Nfib overlying strong GFP expression in the ventricular/sub-ventricular zones. Pink arrows show nuclei immuno-stained for Nfia or Nfib,
while green arrows indicate strong cytoplasmic miR-153-GFP immuno-staining. VZ: ventricular zone; SVZ: subventricular zone; CP: cortical plate. Scale bars:
25 mm.
RESEARCH ARTICLE Biology Open (2014) 000, 1–18 doi:10.1242/bio.20147765
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of miR-153 after ethanol exposure, resulted in the predicted reversal of
transcript expression to control levels (p,0.0002 and p,0.027
relative to ethanol exposure, respectively). Nfic and Hdac8 mRNA
expression was not reversed by subsequent miR-153 over-expression.
However, over-expression of miR-153 after ethanol exposure resulted
in a surprising and significant additional increase in Nfia, Nfib and
Vegfa mRNA transcript levels relative to ethanol exposure alone
(p,0.0004, p,0.0002, and p,0.1E209, respectively). These data
show that simultaneous exposure to miR-153 prevents ethanol
induction of most miR-153 responsive transcripts, while sequential
over-expression of miR-153 after ethanol exposure results in reversal
of ethanol effects on some transcripts. However, sequential exposure
to miR-153 following ethanol also unexpectedly resulted in an
induction of transcripts (Nfia and Nfib) that are direct miR-153 targets.
Fig. 10. Relationship between miR-153 over-expression and the expression of the neuronal differentiation marker DCX, and the neuronal lineage
stem cell marker, CD24 and Map2A, in the cerebral cortical VZ and SVZ. In each row, panel ‘i’ depicts miR-153-GFP or control GFP expression, panel ‘ii’
depicts immunofluorescence for DCX, CD24 or Map2A, panel ‘iii’ depicts combined immunofluorescence and panel ‘iv’ depicts DAPI labeling of cell nuclei.
(a,b) DCX-immunofluorescence is localized to the SVZ, but not VZ (b.ii,c.ii). Control-GFP over-expression (a.i–a.iv) does not alter DCX expression in the SVZ;
however, miR-153 over-expression (b.i–b.iv, circled areas) results in loss of DCX expression in the SVZ. (c–d) CD24-immunofluorescence localizes to VZ and
SVZ in GFP-control (c.i–c.iv) and following miR-153 over-expression (d.i–d.iv). miR-153 over-expression does not result in a loss of CD24 immunofluorescence
(white circles). (e.i–e.iv) MiR-153 over-expression does not result in a loss of MAP2a/b expression in newly generated neurons of the VZ (white circles). VZ:
ventricular zone; SVZ: subventricular zone; CP: cortical plate. Scale bars: 50 mm.
RESEARCH ARTICLE Biology Open (2014) 000, 1–18 doi:10.1242/bio.20147765
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The partial nicotinic agonist, varenicline, induces expression
of miR-153
We previously reported that nicotine, acting at nAChRs, induced
miR-153 expression and prevented the ethanol-mediated
suppression of this miRNA in NSCs (Balaraman et al., 2012).
We therefore re-tested the effect of nicotine on miR-153.
Additionally, we tested the effect of varenicline, a partial
nAChR agonist (Mihalak et al., 2006) and a Food and Drug
Administration (FDA)-approved agent for smoking cessation
(Hartmann-Boyce et al., 2013), because of recent evidence
showing that it is also an effective treatment for alcohol use
disorders (Litten et al., 2013; Steensland et al., 2007). Both
nicotine and varenicline (each at 1.0 mM for 5 days) resulted in a
statistically significant induction of miR-153 expression in
neurosphere cultures (F(2,15)55.621, p,0.015, Fig. 13).
Consistent with the increase in miR-153 expression, in utero
exposure to nicotine (1 mg/kg, twice a day) between GD12.5 and
14.5 resulted in a near complete loss of Nfia (white arrows,
Fig. 11c.i,c.ii vs Fig. 11a.i,a.ii) and Nfib (white arrows,
Fig. 11f.i,f.ii vs Fig. 11d.i,d.ii) immunofluorescence from the
fetal cortical plate.
Varenicline decreases expression of miR-153-dependent
mRNAs and prevents and reverses effects of ethanol
Based on the above data, we hypothesized that varenicline would prevent
and reverse the effects of ethanol exposure on miR-153-regulated
Fig. 11. In utero ethanol exposure results in expanded Nfia and Nfib immuno-labeling in fetal brains while nicotine exposure results in decreased Nfia
and Nfib expression. DAPI-stained sections (a.i–f.i) and their corresponding immuno-fluorescence for Nfia (a.ii–c.ii, and higher magnification inset, a.iii–c.iii) or
Nfib (d.ii–f.ii, and higher magnification inset, d.iii–f.iii) in tissue sections obtained from control (upper panel, a,d), ethanol-exposed (middle panel, b,e), and
nicotine-exposed (lower panel, c,f) fetal brains. Immuno-label for Nfia and Nfib are mainly localized in the developing cortical plate in control animals, but is
spread through the VZ and SVZ in ethanol-exposed animals. White circles in panel ‘ii’ identify regions depicted in panel ‘iii’. Orange arrows identify Nfia and Nfib
immuno-reactivity in mitotically active neuroepithelial cells within the apical region of the VZ, following ethanol exposure. Data obtained from four fetuses in each
condition, each obtained from a separate pregnant dam. CP: cortical plate; SVZ: subventricular zone; VZ: ventricular zone; V: ventricular. Scale bars: 50 mm.
Fig. 12. MiR-153 prevents and partly reverses ethanol’s
effects on miR-153-regulated gene transcripts. Bar graphs
represent real-time RT-PCR analysis for mRNA expression of
miR-153 sensitive genes in control neurosphere cultures
(untreated or transfection control), ethanol (320 mg/dl) alone,
miR-153 over-expression with ethanol exposure (prevention
paradigm), or miR-153 over-expression for 48 hours after 5
days of ethanol exposure (reversal paradigm) of NSCs. The
y-axis indicates normalized mRNA expression (normalized to
18s) relative to control samples. Data were expressed as
mean6SEM. n54 independent experiments. *Significant
difference from control. #Significant difference from ethanol-
exposed. See Results section for p-values.
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mRNAs. In the next series of experiments, we exposed
neurosphere cultures to either control medium, to varenicline
alone, to the ‘prevention paradigm’ (varenicline together with
ethanol for 5 days), or to the ‘reversal paradigm’ (varenicline for
48 hours subsequent to a 5-day episode of ethanol exposure), and
examined the regulation of miR-153 target gene transcripts. In all
conditions, varenicline was administered at 1.0 mM, and ethanol at
a concentration of 320 mg/dl. There was an overall significant
effect (MANOVAPTS, F(27,24)52.36, p,0.018), as well as a
transcript-specific effect of nicotinic activation on miR-153-
regulated transcripts (ANOVAs, F(3,14)Nfia513.51, p,0.0002;
F(3,14)Nfib56.946, p,0.004; F(3,14)Nfic516.1, p,8.15E205;
F(3,14)Ddit4521.8, p,1.5E205; F(3,14)Hdac8521.18, p,1.8E205;
F(3,14)Arl2bp53.55, p,0.04; F(3,14)Vegfa55.031, p,0.014; and
F(3,14)Ccl2510.24, p,0.0008). Consistent with our finding
that varenicline induced miR-153, we found that this partial
nAChR agonist decreased expression of miR-153-target mRNA
transcripts (post hoc fLSD relative to control, pNfia,0.0002,
pNfib,0.003, pNfic,0.0001, pDdit4,0.008, pHdac8,0.0002,
pArl2bp,0.037, pVegfa,0.02, and pCcl2,0.046, Fig. 14).
Moreover, in the ‘prevention paradigm’ (the presence of
varenicline), ethanol exposure did not result in increased mRNA
transcript expression (post hoc fLSD relative to control,
pNfia,0.0003, pNfib,0.003, pNfic,9.82E205, pDdit4,1.8E206,
pHdac8,9.14E206, pArl2bp,0.02, pVegfa,0.01, pCcl2,0.02,
Fig. 14). Finally, in the ‘reversal paradigm’, varenicline exposure
subsequent to ethanol exposure prevented the ethanol-induced
increase in all miR-153 target transcripts (Nfia, Nfib, Nfic, Hdac8,
Arl2bp, and Vegfa, all p5n.s. (not significantly different), or
Ddit4, decreased, p,0.0008, relative to controls). Ccl2 represented
an exception. Varenicline exposure (like miR-153) was unable to
reverse the increase in Ccl2 expression due to previous ethanol
exposure (p,0.006 relative to controls). These data show that
varenicline mimics the effects of miR-153, and like miR-153,
behaves as a functional antagonist to ethanol. Moreover,
varenicline is able to both prevent and largely reverse the effects
of ethanol exposure.
DISCUSSION
Teratogens like ethanol are an established cause of birth defects.
The fetal period of neurogenesis may constitute a particularly
vulnerable period for brain development. Fetal NSCs produce a
majority of neurons of the adult brain between the end of the first
trimester through the second trimester-equivalent period (Bystron
et al., 2008), before switching to gliogenesis during the
third trimester-equivalent period (Miller and Gauthier, 2007).
Therefore, alcohol exposure in the second trimester is likely to
preferentially influence neurogenic programs. We previously
observed in second trimester-equivalent ex vivo and in vivo
models of neurogenesis that ethanol exposure did not result in
NSC death, but instead interfered with NSC renewal and
maturation (Camarillo and Miranda, 2008; Prock and Miranda,
2007; Santillano et al., 2005; Tingling et al., 2013). Ethanol-
targeted miRNAs like miR-153 may mediate and explain some of
ethanol’s teratogenic effects. For example, ethanol’s effects in
neurosphere cultures were mimicked by loss of miRNAs,
including miR-153 (Sathyan et al., 2007), and in a zebrafish
Fig. 13. Nicotine and the nAChR partial agonist varenicline induce miR-
153 expression. Bar graph depicts real-time RT-PCR expression of miR-153
in control, nicotine and varenicline-exposed neurosphere cultures. MiR-153
expression is significantly induced in nicotine and varenicline-treated groups.
The y-axis indicates normalized miR-153 expression (normalized to U6)
relative to control samples. Data were expressed as mean6SEM. n54
independent replicates. Asterisk indicates significant difference from control.
Fig. 14. Varenicline prevents and reverses the effects of
ethanol on miR-153 target gene expression. Bar graph
depicts real-time RT-PCR analysis of mRNA expression of
miR-153-regulated genes in control neurospheres, or
neurospheres treated with varenicline (1 mM) alone,
varenicline in combination with ethanol (prevention
paradigm), and varenicline treatment for 48 hours following
5 days of ethanol exposure (reversal paradigm). The striped
bars show reference ethanol exposure data from Fig. 9. The
y-axis indicates normalized mRNA expression (normalized
to 18s) relative to control samples. Data were expressed as
mean6SEM. n54 independent replicates. *Significant
difference from control. #Significant difference from
ethanol-exposed. See Results section for p-values.
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model, developmental miR-153 knockdown was shown to mimic
ethanol’s effects on both craniofacial development and behavior
(Tal et al., 2012). The question that arises is ‘‘Will identifying
molecular targets of miR-153 provide us with insights into
potential mechanisms for teratogenesis in NSCs?’’.
Microarray and gene ontology analysis shows that miR-153
over-expression repressed cell-signaling pathways including
GPCR pathways, which are important for NSC maturation
(Callihan et al., 2011; Kobayashi et al., 2010). Collectively,
repressed ontology categories were broadly associated with
mature neural function, suggesting that miR-153 served as a
repressor of neuronal differentiation in NSCs. These implicated
ontology categories are consistent with our observations that
miR-153-over-expressing cells exhibit deficient morphological
transformation when cultured in a mitogen-withdrawal
differentiation paradigm. We also observed that miR-153 over-
expression in vivo within the SVZ coincided with loss of DCX
immuno-labeling providing further evidence that miR-153 is a
repressor of neuronal differentiation. We next sought to
determine if miR-153 interfered with neuronal lineage
commitment by examining the expression of CD24, because
previous observations indicated that CD24+ precursors are
committed to neuronal lineage (Nieoullon et al., 2005; Pastrana
et al., 2009; Pruszak et al., 2009; Tingling et al., 2013; Yuan
et al., 2011). However, whereas ethanol exposure resulted in a
loss of CD24+ cells both in vivo and in cell culture (Tingling et al.,
2013), miR-153 over-expression did not result in loss of CD24
expression, suggesting that miR-153, unlike ethanol, does not
interfere with neuronal lineage commitment of VZ and SVZ
precursors, but like ethanol, does interfere with subsequent
neuronal differentiation. MiR-153 over-expression also did not
alter cell survival, and unlike ethanol (Santillano et al., 2005), did
not alter cell proliferation. These data suggest that loss of miR-153
may explain some, but not all, ethanol effects on NSCs. Moreover,
these data are collectively consistent with recent evidence that
miR-153 prevents the development and maturation of motor
neurons (Wei et al., 2013), and serves as a translational repressor
for synaptic and signaling proteins that are important for neuronal
maturation and function (Doxakis, 2010; Long et al., 2012; Wei et
al., 2013). While current analysis focused on miR-153-repressed
transcripts, potential direct effects on induced transcripts cannot be
discounted. MiRNA interactions with promoter regions of mRNA
coding genes reportedly result in increased gene transcription
(Place et al., 2008), and presumptive binding sites on lncRNAs
serve as a mechanism for regulating miRNA function (Hansen et
al., 2013). Therefore, potential interactions of miR-153 with
induced mRNAs and lncRNAs need further assessment.
Conversely, repressed mRNA transcripts like ARL2BP, CCL2
and VEGFA, which did not contain predicted miR-153 binding
sites within their 39UTRs, may be indirect miRNA targets. Their
connection with miR-153 also needs further assessment.
The effects of miR-153 are likely to be mediated by a large
network of both directly and indirectly regulated genes. This
network includes the nuclear factor-1 family, Nfia, Nfib, and
Nfic, which were all suppressed by miR-153 in neurosphere
cultures. Moreover, in utero over-expression of pre-miR-153
coincided with loss of nuclear Nfia/Nfib immunofluorescence,
and miR-153 over-expression in the ventricular zone (VZ)
resulted in disrupted Nfia/Nfib expression in the overlying
cortical plate, suggesting that miR-153 regulates the Nf1 family
in the developing brain. Our data collectively show that members
of the Nf1 family are specific, direct targets of miR-153. Both
Nfia and Nfib possess extended 39UTRs, which are predicted to
assume complex, branched stem–loop structures, and are likely,
as with other long 39UTRs (Irier et al., 2009), to serve as a
focus for regulated, context-dependent translation. In each of
these transcripts, experimental analysis showed the presence of
specific, active miR-153 binding sites that, based on the predicted
folding of the 39UTRs, are in close proximity to both 59 and 39-
termini of the 39UTRs, positioning these sites to influence
translation. Interestingly, other equally strong predicted 39UTR
target sites were found to be non-functional, perhaps because they
are masked in NSCs. However, a role for these cryptic sites at
other stages of neuronal differentiation cannot be discounted.
Since developmental exposure to ethanol suppressed miR-153
expression, we predicted that in utero ethanol exposure would
result in increased expression of Nfia and Nfib. Our data from
both in vivo and neurosphere models show that this is indeed the
case. In vivo, in control animals, at GD15, Nfia and Nfib
expression were mainly localized to the emerging cortical plate
consistent with the published literature (Plachez et al., 2008).
However, following episodes of ethanol exposure, Nfia and Nfib-
like immunofluorescence could be observed throughout the sub-
ventricular and ventricular zones in addition to the cortical plate.
This dysregulated pattern of expression is certainly interpretable
as indicating general exposure-induced delay in fetal
development. However, these data were validated in the
neurosphere culture model where ethanol exposure resulted in
increased expression of Nf1 family transcripts, supporting a direct
relationship between exposure and target gene expression.
While little is known about miR-153, an extensive literature
documents the developmental role of the Nf1 family. During the
neurogenesis period, Nfia and Nfib are dynamically expressed in
differentiating cortical plate neurons (Plachez et al., 2008). Nfia
expression in neuronal lineage-committed precursors and in
young neurons promotes their neural differentiation, but
decreases self-renewal capacity of the remaining NSCs and
causes them to switch from neurogenesis to gliogenesis (Barry
et al., 2008; Deneen et al., 2006; Namihira et al., 2009; Piper
et al., 2010; Wang et al., 2010). Ethanol is a complex teratogen,
and its effects are likely to be broader than those mediated by a
single miRNA and its target mRNA transcripts. However, since
the Nf1 family serves as a feedback inhibitor for NSC self-
renewal (Piper et al., 2010), these data advance an explanation
for the observed loss of NSCs (Santillano et al., 2005; Tingling
et al., 2013), following ethanol exposure. This hypothesized
linkage between miR-153, the Nfia family and fetal alcohol
neurodevelopmental defects needs further assessment especially
in light of associations between Nfia haplo-insufficiency and
brain malformations in human populations (Lu et al., 2007). It is
possible that both over and under-expression of the Nfia
family results in neurodevelopmental defects. Interestingly,
bioinformatics analysis (http://inia.icmb.utexas.edu) indicates
that members of the Nfia family are also up-regulated in human
(Ponomarev et al., 2012) and animal (Mulligan et al., 2006)
models of adult alcoholism. These transcription factors may
constitute a component of both developmental and adult neural
responses to alcohol exposure.
An important question is ‘‘Can we progress beyond the
diagnosis of teratology towards developing intervention
strategies to prevent or even reverse fetal growth defects?’’.
Education strategies aimed at limiting maternal alcohol
consumption have been modestly successful at best, since the
incidence of FAS in the United States has remained constant
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(0.05–0.2% of live births (Bertrand et al., 2005)) over the 40-year
period since the syndrome was first described, while in countries
like South Africa the prevalence rate is reportedly as high as 9%
(May et al., 2013). Therefore alternate approaches, including
biomedical interventional approaches designed to directly
influence fetal development, need further investigation. In this
context, the published literature implicating miRNAs like miR-
153 as mediators of teratogenesis (Sathyan et al., 2007; Tal et al.,
2012) is important, because miRNAs can be manipulated to
promote neuro-protection after the onset of neuro-trauma
(Selvamani et al., 2012). We therefore asked whether
simultaneous over-expression of miR-153 prevented, and
sequential over-expression reversed, ethanol’s effects on target
genes. Our data indicate that simultaneous over-expression of
miR-153 effectively prevents ethanol-mediated induction of miR-
153 targets. Moreover, miR-153 over-expression following
ethanol exposure did reverse the effect of ethanol on some
genes, i.e. Arl2bp and Ddit4. Surprisingly, and contrary to our
prediction, miR-153 over-expression following ethanol exposure
resulted in significantly increased transcript levels of Nfia and
Nfib, even though these transcripts are direct targets of miR-153.
The mechanism for this up-regulation is unknown. It is possible
that the post-ethanol inductive effect of miR-153 on Nfia and
Nfib is indirect, i.e. due to repression of an intermediate
regulatory factor. However, collectively, these data provide the
first promising evidence that miRNA manipulation successfully
prevents, and even partially reverses a teratogen’s effects on
NSCs.
We next assessed the possibility that pharmacological
interventions could prevent the inductive effects of ethanol on
miR-153 target genes. We replicated our previously published
observations (Balaraman et al., 2012) that low-dose nicotine
exposure (at 1 mM) resulted in increased miR-153, and that as
would be predicted, nicotine exposure in vivo, albeit at a
relatively high dose, resulted in loss of expression of miR-153’s
direct targets, Nfia and Nfib, in the fetal cortical plate. Moreover,
low-dose exposure to the partial nAChR agonist, varenicline also
induced miR-153 expression. While varenicline, like nicotine
may well regulate the expression of multiple miRNAs, exposure
to varenicline along with ethanol in the ex vivo neurosphere
model did prevent the ethanol induction of miR-153 target
mRNAs. Importantly, varenicline administration subsequent
to ethanol exposure, reversed the ethanol-induction of nearly
all of the assessed miR-153-regulated transcripts, including
importantly, Nfia/b/c. Varenicline is not only a clinically
effective, FDA-approved, smoking-cessation agent (Hartmann-
Boyce et al., 2013), but has been found to be effective in reducing
alcohol craving in preclinical (Steensland et al., 2007) and human
studies (Litten et al., 2013). Nicotinic receptor-mediated
pharmacotherapies entail complex considerations of dose,
timing and route of delivery (Matta et al., 2007), which are
beyond the scope of the current study. However, these data, as
well as the in vivo effects of nicotine exposure, resulting in
suppression of neural Nfia/b expression, provide a rationale for
further analysis of the therapeutic potential of varenicline, an
agent that provides benefit to the mother by mitigating drug-
seeking behavior, and also effectively mimics miR-153 in
preventing and reversing the effect of a teratogen on fetal NSCs.
Conclusions
Here, we identified a novel and direct inhibitory connection
between a teratogen-targeted miRNA and the neurogenic Nf1
transcription factor family. These data predict an intriguing and
testable hypothesis, i.e. that loss of miRNA control over
neurogenic transcription factors may result in premature NSC
maturation (Fig. 15), perhaps leading to loss renewal capacity,
premature closure of the neurogenic window, and impaired brain
development. Importantly, these data also show, in pre-clinical
models, the translational potential for miRNAs, as a means to
therapeutically intervene in fetal development. Pharmacological
approaches to miRNA manipulation, particularly those involving
nicotinic receptor activation, are certainly controversial in light
of the long-documented teratogenic effects of fetal nicotine
exposure (Nishimura and Nakai, 1958). However, successful
pharmacological interventions to reverse developmental defects
are likely to entail using agents that are themselves teratogenic.
Precedence for using a teratogen to mitigate developmental
defects comes from data showing that the alkaloid teratogen
and hedgehog pathway antagonist, cyclopamine, which causes
craniofacial defects in fetal mice (Lipinski et al., 2008), was
nevertheless able, at sub-teratogenic doses, to partly rescue
craniofacial defects due to genetic ablation of the transcription
factor, SP8 (Kasberg et al., 2013). With careful attention to
factors like dose and timing of exposure, in vivo pharmacological
manipulations of miRNAs and their target gene networks may
well be a feasible approach to prevent and perhaps even reverse
fetal damage following teratogen exposure.
MATERIALS AND METHODS
Isolation and expansion of mouse cortical neural precursors
Timed pregnant mice (C57Bl6-SJ, Harlan Laboratories) were housed in
AAALAC accredited facilities at Texas A&M Health Science Center. All
animal procedures were approved by the University Laboratory Animal
Care Committee. Cortical neuroepithelial tissues were isolated from the
dorsal telencephalic vesicles, corresponding to the region of the future
isocortex, of gestational day (GD) 12.5 mouse fetuses (GD0 was defined
as the day the dams were sperm-positive), and neurosphere cultures were
established according to previously published protocols (Camarillo et al.,
2007; Prock and Miranda, 2007; Santillano et al., 2005). Briefly,
approximately 1,2 million neural precursor cells isolated from the
cortical region from fetuses of both sexes were combined and cultured in
serum-free mitogenic medium DMEM/F12 (number 11330-032; Life
Technologies, CA), 20 ng/ml bFGF (basic fibroblast growth factor;
Fig. 15. Model for the hypothesis that a network of miR-153 and the NF1
neurogenic transcription factor family (Nfia/b/c) mediate the effects of
ethanol on NSC maturation. (a) miR-153 is a direct and negative regulator
of NF1 expression. Our data on miR-153 regulation of gene expression and
published data on NF-1 suggest that suppressing NF1 will in turn retard NSC
maturation, and be predicted to be permissive of continued NSC renewal.
(b) Ethanol suppresses miR-153, resulting in release of NF1 expression,
potentially explaining findings that ethanol promotes NSC maturation.
(c) Nicotinic (nAChR) activation prevents ethanol suppression of miR-153
and may serve to mitigate premature NSC differentiation. Green arrows
depict positive regulation while red bars indicate negative regulation. Dashed
lines indicate diminished regulation, while gray text indicates diminished
expression or function.
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number 354060, BD Biosciences, CA), 20 ng/ml hEGF (human
epidermal growth factor; number 53003-018, Life Technologies, CA),
1% ITS-X (insulin–transferrin–selenium–X; number 51500-056, Life
Technologies, CA), 0.15 ng/ml LIF (leukemia inhibitory factor; number
L200, Alomone Labs), 0.85 U/ml heparin (number 15077-019, Life
Technologies, CA), and 20 nM progesterone (number P6149, Sigma,
MO). Neurospheres were mechanically dissociated into single cells with
medium changed every two or three days. These cultures maintain stem
cell markers and renewal characters (Santillano et al., 2005; Tingling et al.,
2013). To assess the differentiation capacity of control or miR-153 over-
expressing NSC populations, transfected neurospheres were cultured on
laminin-coated (0.5 mg/ml) glass coverslips (number 16004-342; VWR,
PA) in 6-well plates for 48 hours, in a mitogen-withdrawal paradigm
(+bFGF/2EGF/2LIF) that results in stereotypic transformation of NSCs
into early migratory bipolar cells and expression of neuronal markers
(Camarillo et al., 2007; Camarillo and Miranda, 2008). Cultures were fixed
in ice-cold methanol for immunofluorescence analysis.
Neurosphere culture treatment paradigm
Ethanol exposure
Neurosphere cultures containing ,3 million cells were assigned to either
a vehicle control, or an ethanol-treated group (320 mg/dl, 70 mM) for 5
days, to bracket a period equivalent to the peak neurogenic period in the
mouse. The ethanol concentration in culture medium was determined by
an alcohol analyzer (Analox instruments, MA). The particular dose of
ethanol was chosen to reflect levels within ranges attainable during
episodes in chronic alcoholics (Adachi et al., 1991), and is expected to
reflect levels attained by a fetus following prenatal exposure (Gottesfeld
et al., 1990). Four independent samples from either control or ethanol-
treated groups were collected for further analysis.
Varenicline exposure
Varenicline tartrate (Tocris Bioscience, Bristol, UK) at 1.0 mm was
administered alone or in combination with 320 mg/dl ethanol according
to previous protocols established in our laboratory (Balaraman et al.,
2012), and four independent samples from each group were collected for
analysis.
MiR-153 mimetic exposure
The human genome encodes two copies of miR-153 (mir-153-1 and miR-
153-2), whereas the mouse genome encodes a single copy of this miRNA
(Mandemakers et al., 2013). The reported experiments utilized mouse
(mmu)-miR-153 as an experimental model. Furthermore, we focused on a
strategy of miR-153 over-expression rather than repression, as a means to
prevent and reverse ethanol’s effects on NSCs. Neural progenitors were
exposed to mmu-miR-153 mimetic (miRNASelectTM pEGP-mmu-miR-
153 Expression Vector, Cell Biolabs, CA) or control (miRNASelectTM
pEGP-miR Null Control Vector, Cell Biolabs, CA), either alone or in
combination with ethanol at 320 mg/dl. The miRNA expression construct
also encoded a green fluorescent protein (GFP)/puromycin resistance
fusion protein (Fig. 1a) for monitoring transfection efficiency and as a
selection marker. For cell transfection experiments, neurospheres were
collected and trypsinized into a single cell suspension. Cell density was
determined by a CountessH Automated Cell Counter (Life Technologies,
CA). A 10 ml cell suspension containing 3,4 million cells was
transfected by electroporation with 7 mg of either control or miR-153
precursor clone using a NEON electroporator with transfection kit
(settings 1200 V, 20 ms, 2 pulses, Life Technologies, CA). Independent
replicate experiments were harvested for further analysis.
MiRNA and mRNA isolation, mouse whole genome microarray
analysis
MiRNA and mRNA were extracted from harvested cells using a
mirVanaTM miRNA Isolation Kit (number AM1560; Life Technologies,
CA) according to the manufacturer’s protocol. Purified miRNA and mRNA
samples were quantified by NanoDropH ND-1000 UV-Vis
Spectrophotometer (Thermo Scientific, MA). For mRNA microarray
analysis, 1.0 mg of purified mRNA samples from either control or
miR-153 mimetic-treated groups, mixed with 50 pg RNA spike-in
control, were used to generate biotin labeled cRNA samples by a linear
amplification method using Ambion’s MessageAmpTM II-Biotin Enhanced
Single Round aRNA Amplification Kits (number Am1791; Life
Technologies, CA). 10 mg labeled cRNA samples were fragmented at
94 C˚ for 20 minutes, mixed with hybridization buffer (Applied Microarray,
Tempe, AZ) and hybridized with CodeLink whole genome arrays (Applied
Microarray). Post-hybridization processing and secondary-labeling with
CyTM5-conjugated to Streptavidin were performed according to the
manufacturer’s instructions (Applied Microarray). Microarrays were
scanned using a GenePix 4000B scanner (Molecular Devices, Sunnyvale,
CA). A total of 12 microarrays (six in each condition) were used to assess
changes in the transcriptome. Array images were processed using
CodeLinkTM software (Applied Microarray, AZ), and global median
normalization was used to generate normalized expression values. The data
were analyzed further, using GeneSifter Analysis Edition (GSAE,
PerkinElmer-Geospiza, Seattle, WA).
Real-time RT-PCR validation for miRNA and mRNA
MiRNA expression of control and miR-153 mimetic-treated samples was
validated before performing mouse whole genome microarray analysis.
Briefly, 25 ng of purified total RNA was used to generate cDNA, using a
Universal cDNA Synthesis Kit according to the manufacturer’s protocol
(number 203300; Exiqon, Denmark). cDNA samples were diluted 806
and 4 ml was used as a PCR reaction template in a 10 ml PCR reaction.
PCR reactions were run in triplicate on an Applied Biosystems 7900HT
real-time PCR instrument (Applied Biosystems, CA) using a SYBR green-
based real-time PCR reaction kit (number 203450; Exiqon, Denmark) with
miR-153 (number 204338; Exiqon, Denmark) and U6snRNA primer sets
(number 203907; Exiqon, Vedbaek, Denmark). U6snRNA was used as a
normalization control. Real-time RT-PCR data of miRNA expression were
quantified using the SDS 2.4 software package (Applied Biosystems, CA).
Transfection with the miR-153 mimetic resulted in a,30-fold induction of
miR-153 expression relative to control groups, without a statistically
significant change in another ethanol-sensitive miRNA, miR-21 (data not
shown). RT-PCR of mRNA was performed to evaluate expression of
candidate miR-153 target transcripts that were identified in the mouse
whole genome microarray analysis. Total RNA (500 ng) was used to
generate first strand cDNA using qScript cDNA Supermix kit (number
95048-100; Quanta Biosciences, MD). Real-time PCR was performed on a
7900HT Real-Time PCR System (Life Technologies, CA) using the
PerfeCTa SYBR Green SuperMix with ROX kit (number 95053-500;
Quanta Biosciences, Gaithersburg, MD). 2.0 ml of cDNA was used as the
template in a reaction volume of 10 ml. RNA expression was quantified by
calculating the difference between the cycle threshold of the mRNA of
interest, and the reference gene (18s mRNA) for each sample. Specificity
of the amplification was evaluated by thermal stability analysis of the
amplicon. Individual and reference gene primer sets (Integrated DNA
Technologies, Coralville, Iowa) are listed in Table 4.
39UTR analysis of miR-153 candidate genes
Plasmids containing 39UTR firefly/Renilla Duo-Luciferase reporter
luciferase constructs (miTargetTM 39UTR miRNA Targets,
GeneCopoeia, Rockville, MD) were amplified and purified using a
EndoFree plasmid Maxi kit (number 12362; Qiagen, Germantown, MD)
according to manufacturer’s protocol. Purified plasmids were quantified
using a NanoDropH ND-1000 UV-Vis Spectrophotometer (Thermo
Scientific, Waltham, MA). 150 ng of 39UTR construct (Matn2 (number
MmiT031425; GeneCopoeia), Vegfa (number MmiT024368;
GeneCopoeia), Nfia (number MmiT054793; GeneCopoeia), Nfib
(number MmiT027729; GeneCopoeia), pmiR153-Luc (a positive
control for miR-153 translation repression activity, number LR-0064;
Signosis, Sunnyvale, CA)), 100 ng of either control or miR-153 mimetic
expression plasmids (Cell Biolabs, CA), and 10 mm of control or targeted
morpholino antisense, anti-39UTR oligonucleotides (Gene Tools,
Philomath, OR; to protect predicted miR-153 binding sites in 39UTRs
of target mRNA transcripts), were co-transfected into 26104 cells, using
a NEON electroporator according to manufacturer’s protocol (as outlined
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above). At 24 hours after transfection, luciferase signals were determined
by Dual-GloH luciferase assay (number E2920; Promega, Madison, WI),
and quantified using the Synergy-2 multi-mode plate reader (BioTek,
Winooski, VT). Firefly luciferase intensity from each sample was
normalized to the internal control, Renilla luciferase.
Ultrasound-guided in utero electroporation
Ultrasound guided micro-injection procedures were adapted from our
previously published protocol (Tingling et al., 2013). GD13.5 timed
pregnant mice were anesthetized with 4% isoflurane and 0.5% oxygen,
then positioned on a heated mouse platform (Integrated Rail System,
VisualSonics, Toronto, Canada) to monitor temperature, respiration, and
heart rate. Maternal core body temperature was maintained at 33–35 C˚
and maternal heart rate was monitored with adjustments to the level of
anesthesia made to maintain a constant heart rate of ,450 beats/minute.
Following hair removal (NairH hair remover), the skin was sterilized with
ethanol (80% v/v) followed by BetadineH. A midline incision was made
through the skin and peritoneal wall, and one uterine horn was gently
exteriorized through the incision, and carefully drawn through a
ParafilmH flap in the bottom of a sterilized Petri dish. The uterine horn
was completely immersed in warmed ultrasound gel (Ecogel, Eco-Med,
Mississauga, Canada). The brain and lateral ventricle of each fetus was
located by ultrasound imaging (VEVO2100, VisualSonics, Toronto,
Canada). Once the fetal orientation was determined, 5 mg of control or
miR-153 plasmid was injected with a micropipette, under ultrasound
guidance, through the uterine wall, into the fetal lateral ventricle. Fetuses
of either sex were used for microinjection experiments. A forceps-type
electrode connected to a BTX ECM 630 electroporator (4 pulses, each at
35 V and 950 msec duration, Harvard Apparatus, Holliston, MA) was
used to electroporate the plasmid into the fetal telencephalon. Following
electroporation, the uterine horn was reinserted into the peritoneal cavity
and the abdominal wall and skin were closed with sutures. Mice were
sacrificed and the injected embryos were collected after 48 hours
post-transfection. Collected embryos were fixed in 4% buffered
paraformaldehyde, cyro-protected with 30% sucrose, and cryo-
sectioned at 20 mm.
In utero ethanol and nicotine exposure models
Timed pregnant mice were exposed to ethanol (3 gm/kg) or an equivalent
volume of water by intragastric gavage twice daily between GD12.5 and
14.5, bracketing the first half of the second trimester-equivalent period of
cerebral cortical neurogenesis (Takahashi et al., 1995), according to our
previously published protocols (Bake et al., 2012; Sudheendran et al.,
2013; Tingling et al., 2013). The dose of ethanol results in a peak blood
alcohol content of 117 mg/dl (Bake et al., 2012) that can be attained in
humans following binge episodes of ethanol consumption. A second
group of animals were exposed to intra-peritoneal (i.p.) injections of
saline (controls) or nicotine (1 mg/kg free-base, Sigma (N3876); in
saline) twice daily between GD12.5 and 14.5 as outlined above. The
dose, approximating the nicotine content of a cigarette, and route of
exposure were selected based on published literature for mouse studies,
and was twice that of the effective dose for behavioral alterations but less
than 1/5th of the effective dose required for seizure induction (Matta et
al., 2007). At the end of the exposure period, one fetus from each dam
(four each of gavage and i.p. controls and four ethanol- and nicotine-
exposed in total of either sex) was cryo-sectioned and subjected to
immunofluorescence analysis.
Immunofluorescence analysis
Mouse tissue sections and cell cultures were incubated in a blocking
solution (10% normal serum, 0.6% Triton X-100 in PBS) at room
temperature for 1 hour. Tissues were incubated with primary antibody
overnight at 4 C˚ in appropriate dilution (anti-GFP to visualize co-
expression of miR-153 (1:800; number ab13970; Abcam, MA), anti-Nfib
(1:100, number HPA003956; Sigma–Aldrich, MO), anti-Nfia (1:100,
number AP14133b, Abgent, CA), anti-Hdac8 (1:400; number ab39664,
Abcam, MA), anti-DCX (1:800; number ab18723, Abcam, MA) and anti-
CD24 (1:300; number ab64065, Abcam, MA) and MAP2 a&b (Ab5622,
1:300; Millipore). Slides were washed in PBS three times, and Alexa-
Fluor conjugated secondary antibodies were used in order to visualize.
(numbers A11001, A11032, A11037; Life Technologies, CA; numbers
SC-362261, SC-362271; Santa Cruz Biotechnology, CA). Cultured cells
were also immuno-labeled with ant-GFP antibody. Cells and tissues were
mounted with fluorescence mounting medium containing DAPI (number
H-1200; Vector Laboratories, CA) and photographed using an Olympus
microscope.
Cell proliferation assay
DNA synthesis was measured using the Click-iTH EdU cell proliferation
assay (Life Technologies, C-10352) according to our published protocol
(Tingling et al., 2013). Briefly, 46105 cells were treated with 1.5 mg of
the scrambled control-GFP or pre-miR-153-GFP expression vector
Table 4. List of real time RT-PCR primer sequences
Gene name Forward primer Reverse primer
Akt1 AGTCCCCACTCAACAACTTCT GAAGGTGCGCTCAATGACTG
Aplp2 ACTTCACAGAAGCAGCAGCA TCGTGAACAATCTCCTTGTCTG
Arl2bp TGCAGAGAAACTTCATGGACA ATGTTGAAGCCTGGGATACG
Ccl2 TGCTACTCATTCACCAGCAA GTCTGGACCCATTCCTTCTT
Ccl7 GATCCCCAAGAGGAATCTCA CTTCTTGGCTCCTAGGTTGG
Cxcl1 CATCCAGAGCTTGAAGGTGTT AAGGGAGCTTCAGGGTCAAG
Ddit4 ACTCTTCCTTGGTCCCTGGT GCTGCTCGGAGCTGTAGAGT
Fbxo2 CTGTCGGAGAACGAAGATGT TTCCAGTAGACCGAGTCCTG
Foxj2 CTGACATTTCCCGGAAGAGA TTCTCCACTCCCTGGAACAC
Hdac8 AGCCAAGAAGGTGATGAGGA ACCCTCCAGACCAGTTGATG
Il7r ATCCATTCCCCATAACGATT ATGGGCTAAGATGACCAACA
Il13ra1 CCAAGGCAATGACACATACA AAATGAAAGGTGGGCATACA
Mapk3 ACCACATTCTAGGTATCTTGGGT GATGCGCTTGTTTGGGTTGAA
Matn2 GCAGCACGGTCAAGAACGA GAGGGCATATTGGATGGCAAG
Mid1 AGCCTGTGGAGTCCATCAAC GGTCTCACTGGGAGAGTTGG
Mkln1 GGCCATCAAATGGTCATTGACG CAGAGGAATCCAAGTAACGGC
Mtap1s CCATCGCCCTTCGAGTTGTT GCCTTGCTAAGCGCAGAAAG
Nf1a TTCCAACGTCACCCATCATCC CAGCATCAGGACAGACAAGTT
Nf1b CTCAGTGAGAAGCCCGAAATC CAGTCACGGTAAGCACAAAGT
Nf1c CTCACCCACGAGTAGCAGC TTCTTCACCGGGGATGAGATG
Rab13 CAAAGCCTACGACCACCTCT TATGTCCACGGTTCGGATCT
Vegfa TGGATGTCTACCAGCGAAGC ACAAGGCTCACAGTGATTTT
18s ATGGCCGTTCTTAGTTGGTG CGCTGAGCCAGTCAGTGTAG
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followed by incubation with 10 mM EdU (5-ethynyl-29-deoxyuridine) for
16 hours to monitor DNA synthesis. Cells were fixed, washed, and
Incorporated EdU was detected by covalently binding Alexa FluorH 555-
azide. The percent of EdU-labeled cells was then quantified with an
Olympus fluorescence microscope.
Apoptosis assay
Apoptosis was detected by a Homogeneous Caspase Assay (number
03005372001, Roche Applied Science, IN). Briefly, cell aliquots (46105
cells) were treated with 1.5 mg of the scrambled control-GFP or pre-miR-
153-GFP expression vector for 12 hours. Staurosporine (2 mM for
2 hours)-treated neurosphere cultures and U937 cells treated with
camptothecin (4 mg/ml for 4 hours) were used as positive controls.
Caspase activity was measured by adding the diluted caspase substrate
(DEVD-R110) at 37 C˚ for 2 hours. Cleavage of the caspase substrate and
release of the fluorescent dye, Rhodamine 110, was determined at
lmax5521 nm with the fluorescence microplate reader (Tecan Infinite
M200, Switzerland).
Data analyses
Sample sizes from each group ranged from 4 to 6 independent replicates.
Sholl analysis of neurite length was conducted using ImageJ. The total
number of intersections was counted for each cell, as a measure of neurite
extension. Median-normalized mRNA microarray data were analyzed
by T-tests with Benjamin and Hochberg correction for multiple
comparisons, using GeneSifter Analysis Edition (GSEA, Perkin-Elmer/
Geospiza, WA), with a fold-change threshold set at 61.3-fold. Gene
ontology analysis was conducted and z-scores computed for over-
representation analysis. Data from all other experiments were analyzed
by multivariate (Pillai’s trace statistic, MANOVAPTS) or univariate
(ANOVA) analysis of variance. MANOVAs were followed by post hoc
univariate ANOVA, and planned comparisons were further computed
with the Fisher’s least significant difference (f-LSD) test (SPSS v20,
IBM). Single comparison experiments were evaluated with T-tests with
the statistical significance set at p,0.05. Data are expressed as mean6
SEM.
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